Related Experiment Video
Updated: Jan 22, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous
Yuichi Saito1,2, Yoshio Kobayashi3
1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. saitoyuichi1984@gmail.com.
Insights
Optimal antithrombotic therapy for patients with atrial fibrillation (AF) and coronary artery disease undergoing percutaneous coronary intervention (PCI) is unclear. This review examines current evidence on balancing ischemic event reduction with bleeding risk from triple therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation (AF) and coronary artery disease (CAD) frequently coexist.
- Both conditions necessitate antithrombotic therapy to prevent ischemic events.
- Optimal antithrombotic strategies for patients with AF undergoing percutaneous coronary intervention (PCI) are not well-defined.
Purpose of the Study:
- To review current evidence on antithrombotic therapy for patients with AF undergoing PCI.
- To evaluate the efficacy and safety of different antithrombotic regimens.
- To provide insights into updated guideline recommendations.
Main Methods:
- Literature review of recent clinical trials.
- Analysis of guideline updates regarding antithrombotic therapy.
- Synthesis of evidence on triple therapy versus alternative regimens.
Main Results:
- Triple therapy (oral anticoagulant plus dual antiplatelet therapy) is a common initial strategy for AF patients undergoing PCI.
- Triple therapy is associated with a high risk of severe bleeding events.
- Recent trials and updated guidelines offer new perspectives on antithrombotic management.
Conclusions:
- Balancing the prevention of ischemic events and the risk of bleeding is crucial in AF patients undergoing PCI.
- Current evidence suggests a need for individualized antithrombotic approaches.
- Further research is needed to establish definitive optimal therapeutic regimens.
Abstract:
In patients with atrial fibrillation (AF), concomitant coronary artery disease is often present, and vice versa. Although both AF and coronary artery disease need antithrombotic therapy to reduce ischemic events, optimal antithrombotic regimens for patients with AF undergoing percutaneous coronary intervention (PCI) remain unclear. Triple therapy, a combination of oral anticoagulant plus dual antiplatelet therapy with aspirin and P2Y12 inhibitor, has been used for patients with AF undergoing PCI as an initial antithrombotic strategy in the recent decade. However, triple therapy is well-known to induce severe bleeding events. Recently, several clinical trials have been published and guideline recommendations have been updated. This review article summarizes current evidence concerning antithrombotic therapy in patients with AF undergoing PCI.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....